Old drug, new target: can ivermectin cure a stubborn skin parasite?
NCT ID NCT06251739
Summary
This study tested if the drug ivermectin, taken by mouth, is a safe and effective treatment for Post-Kala-Azar Dermal Leishmaniasis (PKDL), a skin disease caused by parasites. It compared ivermectin given over three months to the standard 12-week miltefosine treatment in 30 patients in Bangladesh. The goal was to find a better, shorter, and safer treatment option for this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-KALA-AZAR DERMAL LEISHMANIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
International Centre for Diarrhoeal Disease Research, Bangladesh
Dhaka, Dhaka Division, 1212, Bangladesh
Conditions
Explore the condition pages connected to this study.